Fresenius Kabi Recalls Tranexamic Acid Injection Due to Particulate Matter
Fresenius Kabi USA is recalling 121,456 vials of Tranexamic Acid Injection USP due to the presence of particulate matter consistent with glass vial delamination.
- Product
- Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-10, and 2) Mfd in USA; for Nexus Pharmaceuticals Inc; Vernon Hills, IL 60061.…
- Category
- Drug
- Distribution
- Distributed nationwide